Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Treatment
Volume 2017, Article ID 1793241, 7 pages
https://doi.org/10.1155/2017/1793241
Clinical Study

Pain and Stress Response during Intravenous Access in Children with Congenital Adrenal Hyperplasia: Effects of EMLA and Nitrous Oxide Treatment

1Division of Paediatrics, Department for Clinical Science Intervention and Technology, Karolinska Institute, Karolinska University Hospital, 141 86 Stockholm, Sweden
2Division of Endocrinology, Diabetes and Metabolism, National Childhood Obesity Centre, Karolinska University Hospital, 141 86 Stockholm, Sweden

Correspondence should be addressed to K. Ekbom; es.lls@mobke.nitsrek

Received 23 September 2017; Accepted 30 November 2017; Published 31 December 2017

Academic Editor: Donald A. Simone

Copyright © 2017 K. Ekbom. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Merke and M. Kabbani, “Congenital adrenal hyperplasia: Epidemiology, management and practical drug treatment,” Pediatric Drugs, vol. 3, no. 8, pp. 599–611, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. C. M. Trapp, P. W. Speiser, and S. E. Oberfield, “Congenital adrenal hyperplasia: An update in children,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 18, no. 3, pp. 166–170, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. D. P. Merke and S. R. Bornstein, “Congenital adrenal hyperplasia,” The Lancet, vol. 365, no. 9477, pp. 2125–2136, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. P. W. Speiser, R. Azziz, L. S. Baskin et al., “Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 9, pp. 4133–4160, 2010. View at Google Scholar
  5. H. Falhammar and A. Nordenström, “Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome,” Endocrine Journal, vol. 50, no. 1, pp. 32–50, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. B. L. Linder, N. V. Esteban, A. L. Yergey, J. C. Winterer, D. L. Loriaux, and F. Cassorla, “Cortisol production rate in childhood and adolescence,” Journal of Pediatrics, vol. 117, no. 6, pp. 892–896, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Marumudi, R. Khadgawat, V. Surana, I. Shabir, A. Joseph, and A. C. Ammini, “Diagnosis and management of classical congenital adrenal hyperplasia,” Steroids, vol. 78, no. 8, pp. 741–746, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. C. M. Trapp and S. E. Oberfield, “Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update,” Steroids, vol. 77, no. 4, pp. 342–346, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. F. Witchel, “Non-classic congenital adrenal hyperplasia,” Steroids, vol. 78, no. 8, pp. 747–750, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Bonfig, S. Bechtold, H. Schmidt, D. Knorr, and H. P. Schwarz, “Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: Deceleration of growth velocity during puberty,” The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 5, pp. 1635–1639, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Dauber, M. Kellogg, and J. A. Majzoub, “Monitoring of therapy in congenital adrenal hyperplasia,” Clinical Chemistry, vol. 56, no. 8, pp. 1245–1251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Falhammar and M. Thorén, “Clinical outcomes in the management of congenital adrenal hyperplasia,” Endocrine Journal, vol. 41, no. 3, pp. 355–373, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. E. A. Cummings, G. J. Reid, G. A. Finley, P. J. McGrath, and J. A. Ritchie, “Prevalence and source of pain in pediatric inpatients,” Pain, vol. 68, no. 1, pp. 25–31, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. R. M. Kennedy, J. Luhmann, and W. T. Zempsky, “Clinical implications of unmanaged needle-insertion pain and distress in children,” Pediatrics, vol. 122, supplement 3, pp. S130–S133, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. G. B. Humphrey, C. M. Boon, G. F. van Linden van den Heuvell, and H. B. van de Wiel, “The occurrence of high levels of acute behavioral distress in children and adolescents undergoing routine venipunctures,” Pediatrics, vol. 90, no. 1, part 1, pp. 87–91, 1992. View at Google Scholar
  16. K. Ekbom, J. Jakobsson, and C. Marcus, “Nitrous oxide inhalation is a safe and effective way to facilitate procedures in paediatric outpatient departments,” Archives of Disease in Childhood, vol. 90, no. 10, pp. 1073–1076, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. S. A. Kanagasundaram, L. J. Lane, B. P. Cavalletto, J. P. Keneally, and M. G. Cooper, “Efficacy and safety of nitrous oxide in alleviating pain and anxiety during painful procedures,” Archives of Disease in Childhood, vol. 84, no. 6, pp. 492–495, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Annequin, R. Carbajal, P. Chauvin, O. Gall, B. Tourniaire, and I. Murat, “Fixed 50% nitrous oxide oxygen mixture for painful procedures: A French survey.,” Pediatrics, vol. 105, no. 4, p. E47, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. D. D. Price, F. M. Bush, S. Long, and S. W. Harkins, “A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales,” Pain, vol. 56, no. 2, pp. 217–226, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Miró, E. Castarlenas, and A. Huguet, “Evidence for the use of a numerical rating scale to assess the intensity of pediatric pain,” European Journal of Pain, vol. 13, no. 10, pp. 1089–1095, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Ekbom, S. Kalman, J. Jakobsson, and C. Marcus, “Efficient intravenous access without distress: a double-blind randomized study of midazolam and nitrous oxide in children and adolescents,” Archives of Pediatrics & Adolescent Medicine, vol. 165, no. 9, pp. 785–791, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. D. A. Lowe, M. C. Monuteaux, S. Ziniel, and A. M. Stack, “Predictors of parent satisfaction in pediatric laceration repair,” Academic Emergency Medicine, vol. 19, no. 10, pp. 1166–1172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. M. F. Rolland-Cachera, M. Sempé, M. Guilloud-Bataille, E. Patois, F. Péquignot-Guggenbuhl, and V. Fautrad, “Adiposity indices in children,” The American Journal of Clinical Nutrition, vol. 36, no. 1, pp. 178–184, 1982. View at Google Scholar
  24. K. Glatt, D. L. Garzon, and J. Popovic, “Congenital adrenal hyperplasia due to 21-hydroxylase deficiency,” Journal for Specialists in Pediatric Nursing, vol. 10, no. 3, pp. 104–114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Coyne and L. Kirwan, “Ascertaining children's wishes and feelings about hospital life,” Journal of Child Health Care, vol. 16, no. 3, pp. 293–304, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Weise, S. L. Mehlinger, B. Drinkard et al., “Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 2, pp. 591–597, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. R. D. Sanders, J. Weimann, and M. Maze, “Biologic effects of nitrous oxide: a mechanistic and toxicologic review,” Anesthesiology, vol. 109, no. 4, pp. 707–722, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. D. R. Hoekman, J. Zeevenhooven, F. S. van Etten-Jamaludin et al., “The placebo response in pediatric abdominal pain-related functional gastrointestinal disorders: a systematic review and meta-analysis,” Journal of Pediatrics, vol. 182, pp. 155–163.e7, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Weimer, M. D. Gulewitsch, A. A. Schlarb, J. Schwille-Kiuntke, S. Klosterhalfen, and P. Enck, “Placebo effects in children: a review,” Pediatric Research, vol. 74, no. 1, pp. 96–102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Kankkunen, A.-M. Pietilä, and K. Vehviläinen-Julkunen, “Families' and children's postoperative pain—literature review,” Journal of Pediatric Nursing, vol. 19, no. 2, pp. 133–139, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. D. E. Becker and M. Rosenberg, “Nitrous oxide and the inhalation anesthetics,” Anesthesia Progress, vol. 55, no. 4, pp. 124–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. R. P. P. Moreira, S. M. Villares, G. Madureira, B. B. Mendonca, and T. A. S. S. Bachega, “Obesity and familial predisposition are significant determining factors of an adverse metabolic profile in young patients with congenital adrenal hyperplasia,” Hormone Research in Paediatrics, vol. 80, no. 2, pp. 111–118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Strandqvist, H. Falhammar, P. Lichtenstein et al., “Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: Epidemiological studies in a nonbiased national cohort in Sweden,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 4, pp. 1425–1432, 2014. View at Publisher · View at Google Scholar · View at Scopus